Scotiabank raised the firm’s price target on UiPath (PATH) to $13 from $12 and keeps a Sector Perform rating on the shares. While revenue and margin upside were positives for Q1, the narrow annual recurring revenue, ARR, beat and unchanged FY26 ARR framework does not instill confidence in any meaningful near-term changes, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH: